Metropolitan Life Insurance Company (MetLife)’s Principia Biopharma Inc. Common Stock PRNB Stock Holding History

Metropolitan Life Insurance Company (MetLife)’s Portfolio PRNB Stock Details PRNB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-9,060	Closed	-$542K	–	2611
2020 Q2	$542K	Buy	9,060 +3,203	+55%	+$198K	0.01%	1142
2020 Q1	$348K	Hold	5,857	–	–	0.01%	1268
2019 Q4	$321K	Buy	5,857 +1,051	+22%	+$39.2K	0.01%	1598
2019 Q3	$136K	Buy	4,806 +3,758	+359%	+$138K	﹤0.01%	2134
2019 Q2	$34.8K	Buy	+1,048	New	+$32.7K	﹤0.01%	2536

Other funds holding PRNB

Ohio Public Employees Retirement System (OPERS) Columbus, Ohio $30.9B AUM 29.72% 1-Year Est. Return

Simplex Trading Chicago, Illinois $149B AUM 62.07% 1-Year Est. Return

Skandinaviska Enskilda Banken (SEB) Stockholm, Sweden $2.66B AUM 26.2% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Public Employees Retirement Association of Colorado Denver, Colorado $25.5B AUM 28.85% 1-Year Est. Return

Amalgamated Bank New York $14.5B AUM 44.3% 1-Year Est. Return

Glenmede Trust Philadelphia, Pennsylvania $22.7B AUM

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

ADL

Asset Dedication LLC San Francisco, California $1.59B AUM 26.56% 1-Year Est. Return

Metropolitan Life Insurance Company (MetLife)'s PRNB Position: Q3 2020 in Review

Metropolitan Life Insurance Company (MetLife) sold out of Principia Biopharma Inc. Common Stock (PRNB) in Q3 2020, closing a stake of 9,060 shares — an estimated $542K sold.

Metropolitan Life Insurance Company (MetLife) first reported a position in PRNB in Q2 2019 and held it in 5 quarters. The position peaked at $542K in Q2 2020. 9 funds tracked by Wall St. Rank hold PRNB as of Q3 2020.

Metropolitan Life Insurance Company (MetLife) reported no remaining Principia Biopharma Inc. Common Stock position as of Q3 2020 after selling out during the quarter.
Metropolitan Life Insurance Company (MetLife) sold 9,060 Principia Biopharma Inc. Common Stock shares in Q3 2020, an estimated $542K.
Metropolitan Life Insurance Company (MetLife) first reported a position in Principia Biopharma Inc. Common Stock in Q2 2019 and held it in 5 quarters.
Metropolitan Life Insurance Company (MetLife)'s Principia Biopharma Inc. Common Stock position peaked at $542K in Q2 2020.
9 funds tracked by Wall St. Rank held Principia Biopharma Inc. Common Stock as of Q3 2020.

Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q3 2020, filed 13 Nov 2020.